POPDC1 and cancer: Since PKA and EPAC, which are also downstream effectors of cAMP, make these effects stronger, this suggests that the pro-apoptotic effects of boosted cAMP in cancer cells could be caused, at least in part, by the actions of POPDC1 proteins [182].